Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Moderna Inc
(NQ:
MRNA
)
122.11
+1.71 (+1.42%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Moderna Inc
< Previous
1
2
...
27
28
29
30
31
32
33
34
35
...
99
100
Next >
This High-Growth Company Is Expanding. Time to Buy the Stock?
March 16, 2023
Moderna shares have lost about 15% so far this year.
Via
The Motley Fool
ChatGPT Says These 7 Stocks Could Be the Next Trillion-Dollar Companies
March 15, 2023
Are you looking for the next trillion-dollar companies? Here are the stocks that ChatGPT thinks will help make you rich in the coming years.
Via
InvestorPlace
2 Top Biotech Stocks to Buy for the Long Haul
March 15, 2023
These companies have what it takes to grow their revenues -- and their share prices -- over time.
Via
The Motley Fool
3 Vaccine Stocks to Watch for Their Post-Pandemic Moves
March 14, 2023
The vaccine stocks Pfizer, Moderna, and Novavax all have approved Covid-19 vaccines. They'll soon need new sources of revenue.
Via
InvestorPlace
My Hedge Against The Silicon Valley Bank Crisis
March 14, 2023
In other words, the Fed’s response to today’s banking crisis has turned out to be another catalyst driving gold prices higher.
Via
Talk Markets
Looking At Moderna's Recent Unusual Options Activity
March 14, 2023
Via
Benzinga
Why Moderna Stock Zoomed 7% Higher Today
March 13, 2023
The market takes a prognosticator's new buy recommendation to heart.
Via
The Motley Fool
What 13 Analyst Ratings Have To Say About Moderna
March 13, 2023
Via
Benzinga
Where Will Moderna Be In 5 Years?
March 10, 2023
It might not be making more money in 2028, but it'll likely be a bigger company.
Via
The Motley Fool
Is It Time to Buy the Nasdaq's 3 Worst-Performing February Stocks?
March 14, 2023
It might be the beginning of a long road for this trio.
Via
The Motley Fool
Did Elon Musk Just Put His Skepticism Behind And Warm Up To mRNA Tech That Powers Most COVID-19 Vaccines?
March 14, 2023
Tesla CEO Elon Musk has been a skeptic of the COVID-19 vaccines and highly critical of Dr.
Via
Benzinga
A Bull Market Is Coming: 5 Top Stocks to Buy Now
March 14, 2023
These companies all have solid long-term prospects.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For March 13, 2023
March 13, 2023
Via
Benzinga
Moderna Stock: Bear vs. Bull
March 09, 2023
Moderna stock has soared about 300% over three years.
Via
The Motley Fool
Is It Too Late to Buy Moderna Stock?
March 09, 2023
Its revenue looks about ready to take a skydive that won't be for the faint of heart.
Via
The Motley Fool
2 Top Biotech Stocks to Buy In March and Hold Forever
March 13, 2023
Their price is right, and their future is bright.
Via
The Motley Fool
Moderna To Rally Around 30%? Here Are 10 Other Analyst Forecasts For Monday
March 13, 2023
Morgan Stanley raised the price target for NIKE, Inc. (NYSE: NKE) from $138 to $140. Morgan Stanley analyst Alexandra Steiger maintained an Overweight rating. NIKE shares fell 0.1% to $117.45 in...
Via
Benzinga
A Nasdaq Bull Market Is Coming: 2 Revolutionary Stocks to Buy and Hold
March 12, 2023
It pays to be an innovator.
Via
The Motley Fool
Novavax Stock: Bear vs. Bull
March 10, 2023
The stock has brought investors eye-popping gains and losses over the past few years.
Via
The Motley Fool
Wall Street Thinks These 2 Undervalued Stocks Have Exceptional Growth Potential
March 10, 2023
They're both facing the same fierce headwind, and it won't be going away soon.
Via
The Motley Fool
Looking Into Moderna's Recent Short Interest
March 07, 2023
Via
Benzinga
2 Reasons to Buy Moderna Stock, and 1 Reason to Sell
March 06, 2023
2023 and 2024 will be difficult, but after that, its fortunes should improve again.
Via
The Motley Fool
February’s 7 Worst-Performing S&P 500 Stocks to Buy on the Cheap
March 09, 2023
If you’re a contrarian investor, the best S&P 500 stocks to buy could be companies underperforming in recent times. Here are seven examples.
Via
InvestorPlace
4 Stocks That Moved the Market in February
March 09, 2023
These stocks illustrate last month's most important stock market trends.
Via
The Motley Fool
Sanofi, AstraZeneca Tee Up A Rival To Pfizer In The Multibillion-Dollar RSV Race
March 08, 2023
These companies aren't working on a vaccine, but a monoclonal antibody.
Via
Investor's Business Daily
FDA's Regulatory Delay is The Reason For Novavax, Lucira Health's Failure: WSJ Report
March 07, 2023
Failures of Covid vaccine maker Novavax Inc (NASDAQ: NVAX) and diagnostic start-up Lucira Health Inc (NASDAQ: LHDX) show that companies often succeed or fail, owing to the whims of the government.&nb
Via
Benzinga
5 Stocks ChatGPT Says Will Make Me Rich in 20 Years
March 06, 2023
I asked ChatGPT to recommend me the top 5 biggest growth stocks to buy to get rich within a period of 20 years. Here's what it offered me.
Via
InvestorPlace
Insiders Selling Moderna, Hayward Holdings And 2 Other Stocks
March 06, 2023
The Nasdaq Composite gained more than 200 points on Friday. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
Is It Time to Buy the S&P 500's 4 Worst-Performing Stocks of 2023?
March 05, 2023
Can Lumen Technologies, Moderna, Baxter International, and Pfizer recover this year?
Via
The Motley Fool
Better Growth Stock: Moderna vs. CRISPR Therapeutics
March 05, 2023
Both stocks are ripe for a rebound.
Via
The Motley Fool
< Previous
1
2
...
27
28
29
30
31
32
33
34
35
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.